Methyl 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 25g

1-(3-Sulfopropyl)-2-vinylpyridinium Hydroxide Inner Salt>98.0%(HPLC)25g

N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide, 95.0%, 25g

(R)-1-(4-Chlorobenzyl)pyrrolidin-3-aminedihydrochloride, 95.0%, 1g

Sel disodique de magnésium EDTA x H2O, min 90 %, pour la synthèse, 250 g, emballage plastique.

N-(5,6,7,8-TETRAHYDRONAPHTHALEN-1-YL)ACETAMIDE, 95.0%, 1g

TERT-BUTYL 6-METHYLENE-1,4-OXAZEPANE-4-CARBOXYLATE, 95.0%, 500mg

Pyridinium p-toluenesulfonate, 98.0%, 25g

N-(4-(2-(Dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxybenzamide, 95.0%, 100mg

(4-(tert-Butoxy)phenyl)methanol, 95.0%, 1g

(2R,4S)-1-(tert-Butoxycarbonyl)-4-fluoropyrrolidine-2-carboxylic acid, 95.0%, 5g

2-Chloro-4,5-difluorobenzoic Acid>98.0%(GC)(T)25g

METHYL 5-CHLOROIMIDAZO[1,5-A]PYRIDINE-6-CARBOXYLATE, 95.0%, 250mg